Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Association of lipoprotein lipase gene polymorphisms with obesity and type 2 diabetes in an Asian Indian population

International Journal of Obesity volume 31, pages 913–918 (2007)Cite this article

Abstract

Aims:

Lipoprotein lipase (LPL), a pivotal enzyme in lipoprotein metabolism, catalyzes the hydrolysis of triglycerides of very low-density lipoproteins and chylomicrons. Assuming that the variants in the promoter of the LPL gene may be associated with changes in lipid metabolism leading to obesity and type 2 diabetes, we examined the role of promoter variants (–T93G and –G53C) in the LPL gene in an urban South Indian population.

Methods:

The study subjects (619 type 2 diabetic and 731 normal glucose-tolerant (NGT) subjects) were chosen from the Chennai Urban Rural Epidemiology Study, an ongoing population-based study in southern India. The polymorphisms were genotyped using polymerase chain reaction-restriction-fragment length polymorphism (PCR-RFLP). Linkage disequilibrium (LD) was estimated from the estimates of haplotypic frequencies.

Results:

The two polymorphisms studied were not in LD. The –T93G was not associated with type 2 diabetes but was associated with obesity. 11.5% of the obese subjects (62/541) had the XG(TG+GG) genotype compared with 6.4% of the nonobese subjects (52/809; P=0.001). The odds ratio for obesity for the XG genotype was 1.766 (95% CI: 1.19–2.63, P=0.005). Subjects with XG genotype also had higher body mass index and waist circumference compared with those with TT genotype. With respect to G53C, subjects with the XC(GC+CC) genotype had 0.527 and 0.531 times lower risk for developing type 2 diabetes and obesity, respectively.

Conclusions:

Among Asian Indians, the –T93G SNP of the LPL gene is associated with obesity but not type 2 diabetes, whereas the –G53C SNP appears to be protective against both obesity and type 2 diabetes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Mohan V, Sharp PS, Cloke HR, Burrin JM, Schumer B, Kohner EM . Serum immunoreactive insulin responses to a glucose load in Asian Indian and European Type 2 (non-insulin-dependent) diabetic patients and control subjects. Diabetologia 1986; 29: 235–237.

    Article  CAS  Google Scholar 

  2. Sharp PS, Mohan V, Levy JC, Mather HM, Kohner EM . Insulin resistance in patients of Asian Indian and European origin with non-insulin dependent diabetes. Horm Metab Res 1987; 19: 84–85.

    Article  CAS  Google Scholar 

  3. Misra A, Vikram NK . Insulin resistance syndrome [metabolic syndrome] and Asian Indians. Curr Sci 2002; 83: 1483–1496.

    CAS  Google Scholar 

  4. Chandalia M, Abate N, Garg A, Stray-Gundersen J, Grundy SM . Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999; 84: 2329–2335.

    CAS  Google Scholar 

  5. Ramachandran A, Snehalatha C, Viswanathan V, Viswanathan M, Haffner SM . Risk of noninsulin dependent diabetes mellitus conferred by obesity and central adiposity in different ethnic groups: a comparative analysis between Asian Indians, Mexican Americans and Whites. Diabetes Res Clin Pract 1997; 36: 121–125.

    Article  CAS  Google Scholar 

  6. Joshi SR . Metabolic Syndrome – Emerging clusters of the Indian phenotype. J Assoc Physicians India 2003; 51: 445–446.

    PubMed  Google Scholar 

  7. McKeigue PM, Pierpoint T, Ferrie JE, Marmot MG . Relationship of glucose intolerance and hyperinsulinaemia to body fat pattern in south Asians and Europeans. Diabetologia 1992; 35: 785–791.

    CAS  Google Scholar 

  8. Pradeepa R, Mohan V . The changing scenario of the diabetes epidemic: implications for India. Indian J Med Res 2002; 116: 121–132.

    CAS  PubMed  Google Scholar 

  9. Raji A, Seely EW, Arky RA, Siminson DC . Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 2001; 86: 5366–5371.

    Article  CAS  Google Scholar 

  10. Valsamakis G, Chetty R, Anwar A, Bannerjee AK, Barneet A, Kumar S . Association of simple anthropometric measures of obesity with visceral fat and the metabolic syndrome in male Caucasian and IndoAsian subjects. Diabet Med 2004; 21: 1339–1345.

    Article  CAS  Google Scholar 

  11. Yang W, Huang J, Yao C, Su S, Liu D, Ge D et al. Linkage and linkage disequilibrium analysis of the lipoprotein lipase gene with lipid profiles in Chinese hypertensive families. Clin Sci (Lond) 2005; 108: 137–142.

    Article  CAS  Google Scholar 

  12. Ehrenborg E, Clee SM, Pimstone SN, Reymer PW, Benlian P, Hoogendijk CF et al. Ethnic variation and in vivo effects of the −93t-->g promoter variant in the lipoprotein lipase gene. Arterioscler Thromb Vasc Biol 1997; 17: 2672–2678.

    Article  CAS  Google Scholar 

  13. Schoonjans K, Peinado-Onsurbe J, Lefebvre AM, Heyman RA, Briggs M, Deeb S et al. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J 1996; 15: 5336–5348.

    Article  CAS  Google Scholar 

  14. Auwerx J, Schoonjans K, Fruchart JC, Staels B . Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR. Atherosclerosis 1996; 124: 29–37.

    Article  Google Scholar 

  15. Sartippour MR, Renier G . Differential regulation of macrophage peroxisome proliferator-activated receptor expression by glucose: role of peroxisome proliferator-activated receptors in lipoprotein lipase gene expression. Arterioscler Thromb Vasc Biol 2000; 20: 104–110.

    Article  CAS  Google Scholar 

  16. Michaud SE, Renier G . Direct regulatory effect of fatty acids on macrophage lipoprotein lipase: potential role of PPARs. Diabetes 2001; 50: 660–666.

    Article  CAS  Google Scholar 

  17. Currie RA, Eckel RH . Characterization of a high affinity octamer transcription factor binding site in the human lipoprotein lipase promoter. Arch Biochem Biophys 1992; 298: 630–639.

    Article  CAS  Google Scholar 

  18. Kastelein JJ, Groenemeyer BE, Hallman DM, Henderson H, Reymer PW, Gagne SE et al. The Asn9 variant of lipoprotein lipase is associated with the −93G promoter mutation and an increased risk of coronary artery disease. The Regress Study Group Clin Genet 1998; 53: 27–33.

    Article  CAS  Google Scholar 

  19. Deepa M, Pradeepa R, Rema M, Anjana M, Deepa R, Shanthirani S et al. The Chennai Urban Rural Epidemiology Study (CURES) – Study design and Methodology (Urban Component) (CURES – 1). J Assoc Physicians India 2003; 51: 863–870.

    CAS  PubMed  Google Scholar 

  20. The Asia Pacific perspective: Redefining obesity and its treatment. Regional office for the western Pacific of the World Health Organization World Health Organization, International association for the study of Obesity and International Obesity Task force. Health Communications Australia Pvt Limited 2000; 22–29.

  21. Maniatis T, Fritsch EF, Sambrook J . Molecular Cloning, A Laboratory Manual. Cold Spring Harbor Laboratory: Plainview, NY, 1982; 149–151.

    Google Scholar 

  22. Yang WS, Nevin DN, Iwasaki L, Peng R, Brown BG, Brunzell JD et al. Regulatory mutations in the human lipoprotein lipase gene in patients with familial combined hyperlipidemia and coronary artery disease. J Lipid Res 1996; 37: 2627–2637.

    CAS  PubMed  Google Scholar 

  23. Tanuma Y, Nakabayashi H, Esumi M, Endo H . A silencer element for the lipoprotein lipase gene promoter and cognate double- and single-stranded DNA-binding proteins. Mol Cell Biol 1995; 15: 517–523.

    Article  CAS  Google Scholar 

  24. Hall S, Chu G, Miller G, Cruickshank K, Cooper JA, Humphries SE et al. A common mutation in the lipoprotein lipase gene promoter, −93T/G, is associated with lower plasma triglyceride levels and increased promoter activity in vitro. Arterioscler Thromb Vasc Biol 1997; 17: 1969–1976.

    Article  CAS  Google Scholar 

  25. Staels B, Martin G, Martinez M, Albert C, Peinado-Onsurbe J, Saladin R et al. Expression and regulation of the lipoprotein lipase gene in human adrenal cortex. J Biol Chem 1996; 271: 17425–17432.

    Article  CAS  Google Scholar 

  26. Sheng M, Dougan ST, McFadden G, Greenberg ME . Calcium and growth factor pathways of c-fos transcriptional activation require distinct upstream regulatory sequences. Mol Cell Biol 1988; 8: 2787–2796.

    Article  CAS  Google Scholar 

  27. Enerback S, Ohlsson BG, Samuelsson L, Bjursell G . Characterization of the human lipoprotein lipase (LPL) promoter: evidence of two cis-regulatory regions, LP-alpha and LP-beta, of importance for the differentiation-linked induction of the LPL gene during adipogenesis. Mol Cell Biol 1992; 12: 4622–4633.

    Article  CAS  Google Scholar 

  28. Basu A, Mukherjee N, Roy S, Sengupta S, Banerjee S, Chakraborty M et al. Ethnic India: a genomic view, with special reference to peopling and structure. Genome Res 2003; 13: 2277–2290.

    Article  CAS  Google Scholar 

  29. Devlin B, Roeder K, Wasserman L . Genomic control, a new approach to genetic-based association studies. Theor Popul Biol 2001; 60: 155–166.

    Article  CAS  Google Scholar 

  30. Radha V, Mohan V, Vidya R, Ashok Ayyappa K, Deepa R, Rasika AM . Association of lipoprotein lipase HindIII and Ser 447 Ter polymorphisms with dyslipidemia in Asian Indians. Am J Cardiol 2006; 97: 1337–1342.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The study was supported by a grant from Dr Reddy's Laboratories, Hyderabad. The Chennai Wellingdon Corporate Foundation supported the CURES field studies. This is the 28th paper from the CURES study.

Author information

Authors and Affiliations

  1. Madras Diabetes Research Foundation, Gopalapuram, Chennai, India

    V Radha, K S Vimaleswaran, K Ashok Ayyappa & V Mohan

  2. Dr Mohan's Diabetes Specialities Centre, Gopalapuram, Chennai, India

    V Radha, K S Vimaleswaran, K Ashok Ayyappa & V Mohan

Authors
  1. V Radha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K S Vimaleswaran
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K Ashok Ayyappa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. V Mohan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V Radha.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Radha, V., Vimaleswaran, K., Ayyappa, K. et al. Association of lipoprotein lipase gene polymorphisms with obesity and type 2 diabetes in an Asian Indian population. Int J Obes 31, 913–918 (2007). https://doi.org/10.1038/sj.ijo.0803547

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0803547

Keywords

This article is cited by

Search

Advanced search

Quick links